H
Hautarztpraxis Dr. med. Matthias Hoffmann | Witten, Germany
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Upadacitinib
HRO350
Ruxolitinib
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 6 total trials
The purpose of this study is to evaluate the safety and tolerability of Ruxolitinib cream in participants with Prurigo Nodularis (PN).
Enrolling
Prurigo
Drug: Ruxolitinib Cream
Drug: Vehicle Cream
The objective of this study is to assess the efficacy and safety of upadacitinib for the treatment of adolescent and adult participants with moderate...
Active, not recruiting
Atopic Dermatitis
Drug: Upadacitinib
Drug: Placebo for Upadacitinib
HRO350 contains an oil-based extract from herring roe (Clupea harengus) in soft capsules and contains phospholipids (complex lipids) which are natura...
Active, not recruiting
Psoriasis
Drug: Placebo
Drug: HRO350
Trial sponsors
A
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems